Projects in Progress
Page 1 of 5 (43 results)
-
CDR Review
Latuda
Generic name lurasidone Brand name Latuda Manufacturer Sunovion Pharmaceuticals Inc. Indication Schizophrenia Submission type Resubmission #1 Project Number SR0331 Date submission received 2013-05-09 Patient input deadline 2013-05-31 SUBMITTING_PATIENT_INPUT Status Active Submission status report Recommendation -
CDR Review
Onglyza
Generic name saxagliptin Brand name Onglyza Manufacturer Bristol-Myers Squibb / AstraZeneca Canada Inc. Indication Diabetes mellitus (Type 2) Submission type Pre-NOC Project Number SR0329 Date submission received 2013-05-09 Patient input deadline 2013-05-31 SUBMITTING_PATIENT_INPUT Status Active Submission status report Recommendation -
CDR Review
Picato
Generic name ingenol mebutate Brand name Picato Manufacturer LEO Pharma Inc. Indication Keratosis, actinic Submission type Initial Project Number SR0330 Date submission received 2013-05-09 (Tentative) Patient input deadline 2013-06-07 SUBMITTING_PATIENT_INPUT Status Active Submission status report Recommendation -
CDR Review
Fibristal
Generic name Ulipristal acetate Brand name Fibristal Manufacturer Watson Pharma Company Indication Uterine fibroids (signs and symptoms) Submission type Pre-NOC Project Number SR0326 Date submission received 2013-04-17 Patient input deadline 2013-05-09 Status Active Submission status report Recommendation -
CDR Review
Xarelto
Generic name rivaroxaban Brand name Xarelto Manufacturer Bayer Inc. Indication Thromboembolic events (venous), pulmonary embolism Submission type Initial Project Number SR0327 Date submission received 2013-05-06 Patient input deadline 2013-05-27 SUBMITTING_PATIENT_INPUT Status Active Submission status report Recommendation -
CDR Review
Xarelto
Generic name rivaroxaban Brand name Xarelto Manufacturer Bayer Inc. Indication stroke prevention in patients with atrial fibrillation. Submission type Request for Advice Project Number SR0321-00 Date submission received 2013-03-18 Status Active Submission status report Recommendation -
CDR Review
Pradaxa
Generic name dabigatran Brand name Pradaxa Manufacturer Boehringer Ingelheim (Canada) Ltd Indication Atrial fibrillation prevention of stroke and systemic embolism Submission type Request for Advice Project Number SF0320-000 Date submission received 2013-03-18 Status Active Submission status report Recommendation -
CDR Review
Myrbetriq
Generic name mirabegron Brand name Myrbetriq Manufacturer Astellas Pharma Canada, Inc. Indication Bladder, Overactive Submission type Initial Project Number SR0319 Date submission received 2013-03-08 Patient input deadline 2013-03-29 Status Active Submission status report Recommendation -
CDR Review
Edarbyclor
Generic name Azilsartan medoxomil + chlorthalidone Brand name Edarbyclor Manufacturer Takeda Canada Inc. Indication Hypertension, essential Submission type Initial Project Number SR0318 Date submission received 2013-03-08 Patient input deadline 2013-03-29 Status Active Submission status report Recommendation -
CDR Review
Edarbi
Generic name Azilsartan medoxomil Brand name Edarbi Manufacturer Takeda Canada Inc. Indication Hypertension, essential Submission type Initial Project Number SR0317 Date submission received 2013-03-08 Patient input deadline 2013-03-29 Status Active Submission status report Recommendation